Overall rank by patents
#5,866
of 49,997 tracked assignees
USPTO PatentsView assignee record - 58 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H01S (Devices Using THE Process OF Light Amplification BY Stimulated Emission OF Radiation [LASER] TO Amplify OR Generate LIGHT; Devices Using Stimulated Emission OF Electromagnetic Radiation IN Wave Ranges).
The verdict
According to USPTO PatentsView, Omni ranks #5,866 of 49,997 tracked US assignees by granted-patent volume, with 58 patents across 13 technology areas.
USPTO PatentsView assignee plate
Corpus R5866 · US Corporation #5,866 · 58 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Mattersight Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Head Technology · near
41 score
Omni Medsci · this assignee
41 score
Prolitec · near
41 score
Quidel · near
41 score
Safie · near
41 score
3D Lighting… · lowest
7 score
What this shows Omni's Innovation Score is 40.9/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Omni Medsci, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 94.8% of grants classified under H01S (Devices Using THE Process OF Light Amplification BY Stimulated Emission OF Radiation [LASER] TO Amplify OR Generate LIGHT; Devices Using Stimulated Emission OF Electromagnetic Radiation IN Wave Ranges). Peak complete grant year is 2018 (11 grants) versus a trough of 2 in 2022. By volume, Omni sits between Mattersight Corporation and Prothena Biosciences Limited.
Omni Medsci, Inc. shows 7 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Mattersight Corporation
58 patents
Nippon Thompson Co., Ltd.
58 patents
Nortek Security & Control
58 patents
National Nail Corp.
58 patents
Piksel, Inc.
58 patents
PTC Inc.
58 patents
Polytec GmbH
58 patents
Prothena Biosciences Limited
58 patents
Omni Medsci, Inc.
58 patents
What this shows Omni holds 58 patents at rank #5,866, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #5,866 in granted patent volume.
Other assignees with the most granted patents in Omni's primary technology class.
Two PlainPatent-derived peer sets for Omni, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (41 here).
Nearest assignees by average claims per patent (19.1 here).
Omni's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 8.6% |
| 2016 | 7 | 12.1% |
| 2017 | 5 | 8.6% |
| 2018 | 11 | 19.0% |
| 2019 | 9 | 15.5% |
| 2020 | 4 | 6.9% |
| 2021 | 5 | 8.6% |
| 2022 | 2 | 3.4% |
| 2023 | 3 | 5.2% |
| 2024 | 2 | 3.4% |
| 2025partial year | 5 | 8.6% |
Top 13 of 13 technology areas
Overall rank by patents
#5,866
of 49,997 tracked assignees
40.9 out of 100
What to do with this data
Omni Medsci, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.